Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric AgonistBeatrice Polini, Clementina Manera|Life|2020Cited by 20
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of CB2R modulators in neurodegenerative diseasesRebecca Ferrisi, Francesca Gado, Clementina Manera et al.|Pharmacological Research|2021Cited by 20
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer CellsFrancesca Gado, Clementina Manera|Molecules|2022Cited by 10
CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulatorsFrancesca Gado, Gabriella Ortore, Costanza Ceni et al.|European Journal of Pharmaceutical Sciences|2021Cited by 5